Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study

B F Culleton1, M G Larson, W B Kannel

  • 1National Heart, Lung, and Blood Institute's Framingham Heart Study, Massachusetts 01702, USA.

Insights

Elevated serum uric acid is not a direct cause of heart disease or death. Its apparent link is likely due to other associated risk factors, particularly diuretic use in women.

Area of Science:

  • Cardiovascular epidemiology
  • Metabolic health research

Background:

  • Hyperuricemia is linked to cardiovascular disease (CVD) and mortality.
  • The independent role of uric acid in CVD risk is not fully understood.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and incident coronary heart disease (CHD).
  • To examine the relationship between serum uric acid and cardiovascular disease (CVD) mortality.
  • To assess the link between serum uric acid and all-cause mortality.

Main Methods:

  • A community-based, prospective observational study of 6763 participants from the Framingham Heart Study.
  • Serum uric acid levels were measured at baseline (1971-1976).
  • Event rates were analyzed by sex-specific uric acid quintiles over 117,376 person-years of follow-up.

Main Results:

  • In men, elevated uric acid was not associated with adverse outcomes after age adjustment.
  • In women, uric acid predicted incident CHD, CVD death, and all-cause mortality (P < 0.05).
  • These associations in women disappeared after adjusting for CVD risk factors; diuretic use was identified as a key confounder.

Conclusions:

  • Serum uric acid does not appear to have a causal role in the development of CHD, CVD death, or all-cause mortality.
  • The observed association between uric acid and adverse outcomes is likely explained by its correlation with other risk factors.
  • Diuretic use may confound the relationship between uric acid and cardiovascular outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...